Alzheimer’s Brain Edema, Bleeding Rates Reported in Lecanemab Real-World Study



(MedPage Today) — Treating early Alzheimer’s disease patients with lecanemab (Leqembi) was feasible and most patients tolerated the drug well, a retrospective study at one specialty memory clinic showed.
Infusion-related reactions occurred in…



Source link : https://www.medpagetoday.com/neurology/alzheimersdisease/115551

Author :

Publish date : 2025-05-12 20:22:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version